Clinical Trials Directory

Trials / Unknown

UnknownNCT02782260

Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Ariel University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Subjects with pterygium and associated dry eye symptoms (DES) are randomized into an active cohort (receiving ocular administration of Dipyridamole) or placebo cohort (ocular administration of vehicle). Monthly follow up is conducted for 12 months. Testing conducted at follow up will assess dry eye / pterygium symptoms and endpoints and review the efficacy of the intervention.

Conditions

Interventions

TypeNameDescription
DRUGDipyridamole
DRUGPlacebo

Timeline

Start date
2016-07-01
Primary completion
2017-10-01
Completion
2018-01-01
First posted
2016-05-25
Last updated
2016-05-25

Source: ClinicalTrials.gov record NCT02782260. Inclusion in this directory is not an endorsement.